Danaher Corporation $DHR Shares Sold by Swedbank AB

Swedbank AB decreased its position in shares of Danaher Corporation (NYSE:DHR) by 48.2% during the 1st quarter, HoldingsChannel.com reports. The firm owned 523,130 shares of the conglomerate’s stock after selling 485,921 shares during the quarter. Swedbank AB’s holdings in Danaher were worth $99,185,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also made changes to their positions in the company. JPL Wealth Management LLC purchased a new position in Danaher during the 3rd quarter worth approximately $25,000. Elevated Capital Advisors LLC purchased a new stake in Danaher in the fourth quarter valued at approximately $26,000. WFA of San Diego LLC purchased a new stake in Danaher in the second quarter valued at approximately $26,000. Hilton Head Capital Partners LLC acquired a new stake in shares of Danaher in the fourth quarter valued at approximately $27,000. Finally, Clal Insurance Enterprises Holdings Ltd grew its position in shares of Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after acquiring an additional 53 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Stock Performance

NYSE:DHR opened at $194.17 on Wednesday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The firm has a market cap of $137.42 billion, a price-to-earnings ratio of 37.56, a price-to-earnings-growth ratio of 2.47 and a beta of 0.79. The firm’s fifty day moving average price is $179.65 and its 200 day moving average price is $199.92. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The company had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the prior year, the firm earned $1.88 EPS. Danaher’s quarterly revenue was up 3.7% on a year-over-year basis. On average, sell-side analysts expect that Danaher Corporation will post 8.44 EPS for the current year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is currently 30.95%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. The Goldman Sachs Group cut their target price on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a report on Monday, April 13th. Weiss Ratings downgraded shares of Danaher from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, June 29th. Morgan Stanley dropped their price objective on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. TD Cowen decreased their target price on shares of Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Finally, Evercore reissued an “outperform” rating and set a $230.00 price target on shares of Danaher in a report on Monday. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and a consensus price target of $233.52.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.